Durata Therapeutics: Difference between revisions
Content deleted Content added
No edit summary |
|||
| Line 1: | Line 1: | ||
'''Durata Therapeutics''', established in 2009, is a clinical development stage [[pharmaceutical]] company which focuses on the treatment of [[infectious diseases]]. The company acquired [[dalbavancin]], a long-acting semisynthetic [[lipoglycopeptide]] antibiotic, from [[Pfizer]] in December 2009.<ref>[http://www.genengnews.com/gen-news-highlights/durata-therapeutics-acquires-pfizer-s-subsidiary-that-develops-antibiotics/71646582/ Durata Therapeutics Acquires Pfizer’s Subsidiary that Develops Antibiotics.] GEN News Highlights: Dec 21, 2009.</ref> Durata has initiated two Phase III studies of dalbavancin for intravenous (IV) treatment of acute bacterial skin and skin structure infections.<ref>[http://www.dddmag.com/news-Durata-Begins-Dalbavancin-Study-Enrollment-10511.aspx Durata Begins Dalbavancin Study Enrollment.] Drug Discovery & Development - October 05, 2011.</ref> |
|||
==References== |
|||
{{reflist}} |
|||
==External links== |
|||
* [http://www.duratatherapeutics.com/ Durata Therapeutics corporate website] |
* [http://www.duratatherapeutics.com/ Durata Therapeutics corporate website] |
||
{{Portal|Companies}} |
{{Portal|Companies}} |
||
Revision as of 08:30, 17 November 2014
Durata Therapeutics, established in 2009, is a clinical development stage pharmaceutical company which focuses on the treatment of infectious diseases. The company acquired dalbavancin, a long-acting semisynthetic lipoglycopeptide antibiotic, from Pfizer in December 2009.[1] Durata has initiated two Phase III studies of dalbavancin for intravenous (IV) treatment of acute bacterial skin and skin structure infections.[2]
References
- ^ Durata Therapeutics Acquires Pfizer’s Subsidiary that Develops Antibiotics. GEN News Highlights: Dec 21, 2009.
- ^ Durata Begins Dalbavancin Study Enrollment. Drug Discovery & Development - October 05, 2011.
External links
 | This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |